 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE-- DNA--Twist Bioscience Corporation NASDAQ: TWST, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the closing of its underwritten public offering of 3,211,362 shares of its common stock at a public offering price of 110.00 per share, which consists of 3,136,362 shares sold by Twist, including the exercise in full by the underwriters of their option to purchase up to a 